These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26775708)
1. Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer. Akimoto M; Hayashi JI; Nakae S; Saito H; Takenaga K Cell Death Dis; 2016 Jan; 7(1):e2057. PubMed ID: 26775708 [TBL] [Abstract][Full Text] [Related]
2. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model. Takenaga K; Akimoto M; Koshikawa N; Nagase H PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025 [TBL] [Abstract][Full Text] [Related]
3. ST2 Signaling in the Tumor Microenvironment. Chang CP; Hu MH; Hsiao YP; Wang YC Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890 [TBL] [Abstract][Full Text] [Related]
4. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment. Akimoto M; Maruyama R; Takamaru H; Ochiya T; Takenaga K Nat Commun; 2016 Nov; 7():13589. PubMed ID: 27882929 [TBL] [Abstract][Full Text] [Related]
5. The role of IL-33/ST2L signals in the immune cells. Lu J; Kang J; Zhang C; Zhang X Immunol Lett; 2015 Mar; 164(1):11-7. PubMed ID: 25662624 [TBL] [Abstract][Full Text] [Related]
6. IL-33 signaling fuels outgrowth and metastasis of human lung cancer. Wang C; Chen Z; Bu X; Han Y; Shan S; Ren T; Song W Biochem Biophys Res Commun; 2016 Oct; 479(3):461-468. PubMed ID: 27644880 [TBL] [Abstract][Full Text] [Related]
7. Role of the IL-33/ST2L axis in colorectal cancer progression. Akimoto M; Takenaga K Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638 [TBL] [Abstract][Full Text] [Related]
8. An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer. O'Donnell C; Mahmoud A; Keane J; Murphy C; White D; Carey S; O'Riordain M; Bennett MW; Brint E; Houston A Br J Cancer; 2016 Jan; 114(1):37-43. PubMed ID: 26679377 [TBL] [Abstract][Full Text] [Related]
9. IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer. Yang YE; Hu MH; Zeng YC; Tseng YL; Chen YY; Su WC; Chang CP; Wang YC Cell Death Dis; 2024 May; 15(5):356. PubMed ID: 38778059 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Porgador A; Tzehoval E; Katz A; Vadai E; Revel M; Feldman M; Eisenbach L Cancer Res; 1992 Jul; 52(13):3679-86. PubMed ID: 1617640 [TBL] [Abstract][Full Text] [Related]
13. KU812 cells provide a novel in vitro model of the human IL-33/ST2L axis: functional responses and identification of signaling pathways. Tare N; Li H; Morschauser A; Cote-Sierra J; Ju G; Renzetti L; Lin TA Exp Cell Res; 2010 Sep; 316(15):2527-37. PubMed ID: 20406635 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells. Schmieder A; Multhoff G; Radons J Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319 [TBL] [Abstract][Full Text] [Related]
15. The role of interleukin-33 in chronic allergic conjunctivitis. Matsuda A; Okayama Y; Terai N; Yokoi N; Ebihara N; Tanioka H; Kawasaki S; Inatomi T; Katoh N; Ueda E; Hamuro J; Murakami A; Kinoshita S Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4646-52. PubMed ID: 19458329 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680 [TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Nishida A; Andoh A; Imaeda H; Inatomi O; Shiomi H; Fujiyama Y Gut; 2010 Apr; 59(4):531-41. PubMed ID: 19996325 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Li J; Zhang L; Zhang J; Wei Y; Li K; Huang L; Zhang S; Gao B; Wang X; Lin P Carcinogenesis; 2013 Mar; 34(3):658-66. PubMed ID: 23250909 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity. Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]